Upload
welky-vernando
View
217
Download
0
Embed Size (px)
Citation preview
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
1/65
Hypertension: Medical Management
and Nutritional Approaches
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
2/65
Circuits
Pulmonary circuitThe blood pathway
between the right side of the
heart, to the lungs, and back
to the left side of the heart.
Systemic circuit
The pathway between the
left and right sides of theheart.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
3/65
Distribution of Blood in the Body Organs
Figure 15-13: Distribution of blood in the body at rest
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
4/65
Regulation of Blood Pressure
Figure 15-22: The baroreceptor reflex: the response to increased blood pressure
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
5/65
Baroreceptor and ChemoreceptorReflexes
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
6/65
Hypertension
Persistently high arterial blood
pressure
Systolic blood pressure above 140
mm Hg and/or diastolic blood
pressure above 90 mm Hg
Normotensive = 120/80 mm Hg
Prehypertensive = 120139/80-89
mm Hg
Stage 1 hypertension = 140159/90-
99 mm Hg
Stage 2 hypertension = >160/>100
mm Hg
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
7/65
Prevalence and Incidence
29% of adult US population
Related to body mass index
High prevalence in African Americans
5% of pediatric population; prevalence increases
with age
Strong positive relationship between blood pressure
and risk of CVD events
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
8/65
Pathophysiology
Blood pressure is a function of cardiac output
multiplied by peripheral resistance
Affected by diameter of blood vessel
Atherosclerosis decreases diameter, increases bloodpressure
Drug therapy increases diameter, lowers blood
pressure
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
9/65
Circulatory Systems in the Body
1. Coronarysupplies blood to heartmuscle (can form collateralcirculation)
2. Cerebralsupplies blood to head3. Splanchnicsupplies blood to
abdomen (exercise removes blood
and food attracts blood to this area)4. Pulmonarysupplies blood to lungs
(O2 and CO2 exchange)
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
10/65
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
11/65
Determinants of Blood Pressure
1. Blood volume
2. Vascular resistance to pressure
3. Heart stroke volume
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
12/65
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
13/65
Vascular Resistance
Viscosity of blood
Width of vessels(constriction or
dilation)controlled by muscle tone invessel walls
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
14/65
Regulation of Blood Pressure
1. Sympathetic nervous system (SNS)respondsimmediately; baroreceptors monitor BP
Vasomotor center in brain
SNS innervated tissues contract or dilate vascularbed
2. Renin-angiotensin systemretains Na and H2O to
increase blood volume; constricts blood vessels;increases aldosterone
3. Kidneysrespond to renin-angiotensin system;aldosterone and antidiuretic hormone (ADH) are sent
out as needed
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
15/65
Homeostatic Control ofBlood Pressure
Short term
Sympathetic nervous system
VasoconstrictionVasodilation
Long term
Fluid volumeRenin-angiotensin system
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
16/65
Hypertension
1. 90% HTN is essential HTN (cause unknown;
perhaps prenatal impacts?)
2. 10% HTN is secondary to other diseases
3. HTN is a risk factor for MI, CVA, renal failure
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
17/65
Renin-Angiotensin Cascade
Redrawn from Guyton AC: Textbook of medical physiology, ed 8, Philadelphia, 1991, WB Saunders.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
18/65
Causes of Hypertension
Algorithm content developed by John Anderson, PhD, and Sanford C. Garner, PhD, 2000.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
19/65
Identifiable causes of hypertension Chronic kidney disease\
Coarctation of the Aorta Cushings Syndrome
Drug induced
Obstructive uropathy
Pheochromocytoma Primary aldosteronism and other mineralocorticoid excess
states
Renovascular HTN stenosis and fibromuscular dysplasia
Sleep Apnea Thyroid (either HYPER or HYPO) or parathyroid disease
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
20/65
Risk Factors for Developing
Hypertension
(Adapted from National High Blood Pressure Education Program Working Group report on primary prevention of hypertension.
Arch Intern Med 153:186, 1993. Copyright 1993, American Medical Association. Reprinted with permission.)
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
21/65
Risk Stratification in Patients with
Hypertension
(From The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. sixth report
(JNC VI). Arch Intern Med 157:2413, 1997.)
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
22/65
Uncontrolled Hypertension
Leads to increased
Workload on heart
Damage to arteries
Atherosclerosis
Coronary heart disease esp. CHF
Strokes
Transient ischemic attacks (TIAs)
Kidney damage
Microvascular hemorrhages in brain and eye
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
23/65
The DASH Diet Trials
Randomized feeding trial comparing effects of 3 diet
patterns: control, high fruits/vegetables, and high
fruits/vegetables/whole grains/lowfat dairy (DASH diet)
DASH diet high in potassium, magnesium, calcium,fiber and low in fat, saturated fat, and cholesterol
DASH diet significantly lowered BP in all groups, but
especially in African-Americans
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
24/65
Effects of Diet on BP (DASH Trial)
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
25/65
For persons over age 50, SBP is a more important
than DBP as CVD risk factor.
Persons who are normotensive at age 55 have a 90%
lifetime risk for developing HTN.
Those with SBP 120139 mmHg or DBP 8089 mmHg
should be considered prehypertensive who require
health-promoting lifestyle modifications to prevent
CVD.
New Features and Key Messages
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
26/65
New Features and Key Messages(Continued)
Thiazide-type diuretics should be initial drug therapy for
most, either alone or combined with other drug classes.
Certain high-risk conditions are compelling indications forother drug classes.
Most patients will require two or more antihypertensive
drugs to achieve goal BP.
If BP is >20/10 mmHg above goal, initiate therapy with two
agents, one usually should be a thiazide-type diuretic.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
27/65
Blood Pressure Classification
Normal 100
BP Classification SBP mmHg DBP mmHg
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
28/65
CVD Risk
HTN prevalence ~ 50 million people in the United States.
The BP relationship to risk of CVD is continuous, consistent,
and independent of other risk factors.
Each increment of 20/10 mmHg doubles the risk of CVD
across the entire BP range starting from 115/75 mmHg.
Prehypertension signals the need for increased education to
reduce BP in order to prevent hypertension.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
29/65
Benefits of Lowering BP
Average Percent Reduction
Stroke incidence 3540%
Myocardial infarction 2025%
Heart failure 50%
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
30/65
BP Control Rates
Trends in awareness, treatment, and control of highblood pressure in adults ages 1874
National Health and Nutrition Examination Survey, Percent
II
197680
II(Phase 1)
198891
II(Phase 2)
199194 19992000
Awareness 51 73 68 70
Treatment 31 55 54 59
Control 10 29 27 34
Sources: Unpublished data for 19992000 computed by M. Wolz, National Heart, Lung, and Blood Institute; JNC 6.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
31/65
BP Measurement Techniques
Method Brief Description
In-office Two readings, 5 minutes apart, sitting in
chair. Confirm elevated reading in
contralateral arm.Ambulatory BP monitoring Indicated for evaluation of white-coat HTN.
Absence of 1020% BP decrease during
sleep may indicate increased CVD risk.
Self-measurement Provides information on response to therapy.May help improve adherence to therapy and
evaluate white-coat HTN.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
32/65
CVD Risk Factors
Microalbuminuria orestimated GFR 30 kg/m2)
Physical inactivity
Dyslipidemia*
Diabetes mellitus*
*Components of the metabolic syndrome.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
33/65
Target Organ Damage
Heart Left ventricular hypertrophy
Angina or prior myocardial infarction
Prior coronary revascularization
Heart failure
Brain
Stroke or transient ischemic attack
Chronic kidney disease
Peripheral arterial disease
Retinopathy
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
34/65
Goals of Therapy
Reduce CVD and renal morbidity and mortality.
Treat to BP
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
35/65
Lifestyle Modification
Modification Approximate SBP reduction
(range)
*Weight reduction 520 mmHg/10 kg weight loss
*Adopt DASH eating plan 814 mmHg
*Dietary sodium reduction 28 mmHg
Physical activity 49 mmHg
*Moderation of alcohol
consumption
24 mmHg
*medical nutrition therapy interventions
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
36/65
Classification ofAntihypertensive Drugs
Diuretics
Thiazides
Loop diuretics
Potassium-sparing diuretics Beta blockers (BB)
Angiotensin II receptor blockers (ARBs)
Alpha-beta blockers
Alpha1 receptor blockers ACE inhibitors (angiotensin converting enzyme)
Calcium antagonists
Direct vasodilators
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
37/65
Algorithm for Treatment of Hypertension
Not at Goal Blood Pressure (100 mmHg)
2-drug combination for most (usually
thiazide-type diuretic and
ACEI, or ARB, or BB, or CCB)
Stage 1 Hypertension(SBP 140159 or DBP 9099 mmHg)
Thiazide-type diuretics for most.
May consider ACEI, ARB, BB, CCB,
or combination.
Without CompellingIndications
Not at Goal
Blood Pressure
Optimize dosages or add additional drugs
until goal blood pressure is achieved.
Consider consultation with hypertension specialist.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
38/65
Compelling Indications
These are reasons for using a particular class ofmedications
For example, patients with diabetes, kidney damage,and high blood pressure should begin treatment with
ACE inhibitors.
Heart attack (in conjunction with hypertension) is acompelling indication for the prescription of beta-blockers and, in certain instances, ACE inhibitors
Heart failure should first be treated with ACE inhibitorsand diuretics.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
39/65
Classification and Managementof BP for adults
BP
classification
SBP*
mmHg
DBP*
mmHg
Lifestyle
modification
Initial drug therapy
Without compelling
indication
With compelling
indications
Normal 100 Yes Two-drug combination for
most (usually thiazide-type
diuretic and ACEI or ARB or
BB or CCB).
*Treatment determined by highest BP category.Initial combined therapy should be used cautiously in those at risk for orthostatic hypotension.
Treat patients with chronic kidney disease or diabetes to BP goal of
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
40/65
Minority Populations
In general, treatment similar for all demographic groups.
Socioeconomic factors and lifestyle important barriers to BP control.
Prevalence, severity of HTN increased in African Americans.
African Americans demonstrate somewhat reduced BP responses to
monotherapy with BBs, ACEIs, or ARBs compared to diuretics or
CCBs.
These differences usually eliminated by adding adequate doses of a
diuretic.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
41/65
Children and Adolescents
HTN defined as BP95th percentile or greater, adjusted for age,
height, and gender.
Use lifestyle interventions first, then drug therapy for higher levels ofBP or if insufficient response to lifestyle modifications.
Drug choices similar in children and adults, but effective doses are
often smaller.
Uncomplicated HTN not a reason to restrict physical activity.
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
42/65
Lifestyle Modifications
Sodium: not more than 2.4 grams sodium/day
Activity: activity like brisk walking 30 minutes/day most
days of the week
Alcohol: not more than 1 drink a day for women; 2drinks a day for men
DASH diet: low in sodium, high in potassium, calcium,
cholesterol, saturated fat
Weight: weight loss of as little as 10 lb can prevent or
treat high blood pressure
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
43/65
Weight Management
Risk of developing high blood pressure is 2-6 times
higher in overweight than normal weight persons
20-30% of the hypertension in the US is attributable to
excess weight In Framingham, weight increase of 10% predicted rise
in blood pressure of 7 mm/hg
Weight gain during adult life is responsible for much of
the rise in blood pressure seen with aging
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
44/65
Weight Management
Excess body weight may increase blood pressurethrough increased insulin resistance andhyperinsulinemia, activation of the sympathetic nervousand renin-angiotensin systems, and changes in the
kidney Weight loss lowers vascular resistance, total blood
volume, cardiac output, and sympathetic nervoussystem activity; improves insulin resistance
Weight loss in an overweight person is the single mosteffective lifestyle intervention to reduce blood pressure
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
45/65
Weight Management
In the Trial of Antihypertensive Intervention and
Management, goal for energy intake to facilitate weight
loss was 25 kcals/kg minus 500 to 1000 kcal daily to
produce a .5 to 1 kg weight loss/week to achieve totalweight loss of 4.5 kg.
Wylie-Rosett et al, 1993
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
46/65
Sodium and Hypertension
Relationship between sodium and hypertension is strongerin
Older people
Those with a family history of hypertension Those with higher blood pressures at baseline
30-50% of hypertensives and 15-25% of normotensivesare salt sensitive
Salt sensitivity more common in black race, obesity,advanced age, diabetes, renal dysfunction, use ofcyclosporine
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
47/65
Sodium and Hypertension
Addition of a sodium restriction to a DASH diet lowers
SBP 3 mmHg and DBP 2 mmHg
This reduction is associated with a 17% reduction in
prevalence of hypertension, 6% reduction in CHD, 15%reduction in stroke and TIA
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
48/65
Salt Restriction
Recommendation is for moderate salt restriction (6
grams salt, 100 mEq or 2400 mg Na daily)
Salt is the issue, because chloride ion with sodium
raises blood pressure May normalize blood pressure in Stage 1 hypertension
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
49/65
Levels of Na Restriction
g Na mEq Na Description
4 174 No added salt
2-3 87-130 Mild to moderate
restriction1 43 Strict sodium restriction
0.5 22 Severe sodium restriction
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
50/65
Alcohol and Hypertension
5-7% of hypertension is due to alcohol
consumption
3 drinks per day is the threshold for raisingblood pressure; associated with a 3 mmHg
increase
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
51/65
Physical Activity and Hypertension
Less active persons are 30-50% more likely to develop
hypertension than active persons
Medium to high levels of activity protective against
stroke (Framingham) Walking reduces blood pressure in adults by an
average of 2%
In a meta-analysis of 54 randomized trials, walking
reduced blood pressure an average of 4 mmHg,
irrespective of weight change
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
52/65
Potassium
In population studies, potassium intake and blood
pressure are inversely related
Sodium/potassium ratio is important
Sodium/potassium ratio of 1:1 a 3.4 mmHg decrease insystolic BP is predicted
High potassium intake inversely related to stroke
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
53/65
Other Factors
Calcium, Magnesium, and Lipids: role still unclear
DASH diet high in lowfat dairy products
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
54/65
Response to Dietary Rx
Salt sensitive respond well to sodium restriction
Most respond to increased potassium in diet.
1.1 to 3.3 g Na is safe
1.9 to 5.6 g K is recommended to achieve ratio Na:K of1, which is goal
If taking a potassium-wasting diuretic drug, increasedpotassium in diet is essential.
Most respond to increased calcium (at least the RDA)usethe DASH diet protocol
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
55/65
DASH Diet
Works within 14 days
Lowers BP quite well
Includes more potassium, calcium,
other nutrients
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
56/65
DASH Fact Sheet
www.nhlbi.nih.gov/heal
th/public/heart/hbp/dash/
new_dash.pdf
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
57/65
DASH Diet contd
Pattern
7-8 whole grains
4-5 vegetables
4-5 fruits
2-3 low-fat or fat-free dairy products
6 oz or less meat/poultry/fish
4-5 servings nuts, beans, or legumes/week2-3 servings fat (total kcal = 27% fat)
DASH Diet Patterns for
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
58/65
DASH Diet Patterns forDifferent Calorie Levels
Kcals Grain Veg Fruit Dairy Meat/
Pro
Nuts/
Legume
Fats/
oils
1600 6 4 4 2 1 .5 1
2000 8 5 5 3 2 1 2
2600 10 5 5 3 2 1 2
3100 13 6 6 4 2 1 3
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
59/65
Sodium
Processed and restaurant foods provide 80% of sodiumintake
Read labels; sodium content of different brands varies
10% added in cooking at home and at table; 10% naturally
occurring Americans consume ~4,000 mg/day; 2005 Dietary Guidelines
for Americans recommend
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
60/65
Food Label Terms
Sodium free, no sodium =
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
61/65
Salt Substitutes
Composition: KCl, CaCl, Al-Cl KCl can provide extra potassium for those taking
diuretics
KCl can be harmful if patient has renal insufficiency
Lite salt contains sodium
Some spices and herbs are low in sodium
Others are high in sodium
Classification of
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
62/65
Classification ofAntihypertensive Drugs
Diuretics
Thiazides
Loop diuretics
Potassium-sparing diuretics Beta blockers (BB)
Angiotensin II receptor blockers (ARBs)
Alpha-beta blockers
Alpha1 receptor blockers ACE inhibitors (angiotensin converting enzyme)
Calcium antagonists
Direct vasodilators
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
63/65
Renin-Angiotensin Aldosterone System
Angiotensinogen
Non-ACE pathways(eg, chymase)
Vasoconstriction
Cell growth
Na/H2O retention
Sympathetic activation
Renin Angiotensin I
Angiotensin II
ACE
Cough,
angioedema
Benefits? Bradykinin
Inactive
fragments
Vasodilation
Antiproliferation
(kinins)
Aldosterone AT2
AT1
Lif t l M difi ti f P ti f
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
64/65
Lifestyle Modifications for Prevention ofHypertension
Lose weight if overweight
Limit alcohol
Increase physical activity
Decrease sodium intake Keep potassium intake at adequate levels
Take in adequate amounts of calcium and magnesium
Decrease intake of saturated fat and cholesterol Stop smoking
7/28/2019 UNIBA Hypertension With Jnc7 and Mnt 28-6-12
65/65
Summary
Lifestyle modifications for prevention of hypertension
quite effective!
Management of hypertensionvery important to reduce
risk of heart attack or stroke